Gannex Published Phase I Data of ASC42, a Novel Farnesoid X Receptor Agonist on the Journal Drugs in R&D
Gannex Pharma Co., Ltd., a wholly-owned company of Ascletis Pharma Inc. announces that the safety, pharmacokinetics, and pharmacodynamics data of ASC42, a novel farnesoid X receptor agonist, in healthy subjects have been published on the journal Drugs in R&D.
